Pdt Partners, LLC Personalis, Inc. Transaction History

Pdt Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.89 - $5.32 $286 - $526	-99 Reduced 0.38%	25,847 $77,000
Q2 2022 Aug 15, 2022	BUY	$3.27 - $8.76 $84,843 - $227,286	25,946 New	25,946 $90,000
Q1 2022 May 16, 2022	SELL	$7.56 - $14.3 $139,580 - $264,020	-18,463 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.24 - $21.25 $157,381 - $273,232	-12,858 Reduced 41.05%	18,463 $263,000
Q3 2021 Nov 15, 2021	SELL	$16.69 - $26.05 $2.42 Million - $3.78 Million	-145,079 Reduced 82.24%	31,321 $603,000
Q2 2021 Aug 16, 2021	BUY	$18.15 - $27.75 $668,990 - $1.02 Million	36,859 Added 26.41%	176,400 $4.46 Million
Q1 2021 May 17, 2021	BUY	$20.71 - $51.02 $1.22 Million - $3 Million	58,848 Added 72.93%	139,541 $3.43 Million
Q4 2020 Feb 16, 2021	BUY	$21.84 - $44.0 $1.19 Million - $2.4 Million	54,577 Added 208.98%	80,693 $2.95 Million
Q3 2020 Nov 16, 2020	BUY	$13.63 - $24.12 $355,961 - $629,917	26,116 New	26,116 $566,000

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $159M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.